The growing popularity of weight loss drugs is clearly evident in Rho's business, which offers both GLP-1 drug options, as well as alternative versions. Although these alternative drugs currently represent a minority of Rho's business, they are one of the fastest growing categories due to high demand and shortages of GLP-1 drugs.
Bloomberg TV provided by MT Newswires
